 |
|
| |
| |
 |
Barry
Hardy
Conference Chair |
|
|
 |
Christophe
Cleva
Serono Pharmaceutical Research Institute |
|
|
| |
|
|
| |
 |
Andrew
Lemon
ID Business Solutions Ltd |
|
|
 |
Karl Harrison
Oxford University |
|
|
|
| |
| |
 |
Gregory
M. Banik
Bio-Rad Laboratories, Inc |
|
|
 |
Alex
Tropsha
University of North-Carolina |
|
|
| |
 |
Mark
Mackey
Cresset BioMolecular Discovery Ltd
|
|
|
|
|
| |
| |
 |
Prof.
Vladimir Poroikov
V.N. Orekhovich Institute of Biomedical Chemistry of Rus.Acad.
Med. Sci. |
| |
|
 |
Paul Blower
Leadscope
|
| |
|
| |
 |
Mitchell
Miller
Lion Bioscience
|
| |
|
|
|
| |
| |
|
Zsolt
Zsoldos
SimBioSys, Inc
|
| |
|
|
Bradley
P. Feuston
Merck
|
| |
|
| |
 |
Miklos
Vargyas
Chemaxon
|
| |
|
|
|
| |
| |
 |
Jeff
Saffer
Omniviz
|
| |
|
 |
David
Lloyd
De Novo Pharmaceuticals
|
| |
|
|
| |
| |
 |
Alessandro
Contini
Universita degli Studi di Milano
|
| |
|
 |
Matteo
Floris
University of Padova |
| |
|
| |
  |
Lorie
Karnath/Jeff Spitzner
Rescentris
|
| |
|
 |
Robert
Scoffin
CambridgeSoft
|
| |
|
| |
 |
John
J. Irwin/Brian K. Shoichet
UCSF Pharmaceutical Chemistry |
| |
|
|
|
| |